Delivery Order SPE2DB22D1017-SPE2DB25FG7RA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,126.74 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16 unit dose tablets) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and running through December 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.80 firm fixed-price delivery order is for the supply of UBRELVY 100 MG TABLET UD 10S, a medication used for the treatment of migraines. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The $4,115.14 firm fixed-price contract has a period of performance through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The order has a ceiling value of $8,337.85 and a completion date of July 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,657.18 firm fixed-price contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a medication used to treat migraines. The contract has a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of UBRELVY 100 mg tablets, a medication used to treat migraine. The contract has a firm fixed price of $1,247.95 and a performance period ending on June 13, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a...
- Defense Logistics Agency Troop Support Medical awarded a $777 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 100 mg tablets of UBRELVY in quantities of 10 tablets per package. Performance will occur in Conshohocken, Pennsylvania by October 13, 2023. The contract was unrestricted with no set-aside designation. As the Defense Logistics Agency supports the medical needs of service members, this order for UBRELVY, used to...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication UBRELVY 100 MG TABLET UD 10S. The contract has a ceiling value of $1,479.30 and is a firm fixed-price, non-set-aside contract type with a performance period ending on May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $15,597.85 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a prescription medication, with a completion date of June 11, 2025. The contract is not set aside for any particular business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of UBRELVY 100 MG TABLET UD 16S. The contract is a Firm Fixed Price (FFP) delivery order with a ceiling value of $2,331.12 and a period of performance through July 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7RADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,357.50 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (unit dose, 10-count packages) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This delivery order represents a routine pharmaceutical procurement supporting federal military and veteran healthcare systems through AmerisourceBergen's comprehensive global pharmaceutical supply vehicle. UBRELVY is a migraine treatment medication, consistent with the company's extensive portfolio of brand-name and generic pharmaceuticals, specialty medications, and medical supplies delivered across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The SPE2DX contract serves as a flexible procurement mechanism enabling DLA to fulfill ongoing pharmaceutical requirements for military operations and healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/18/25 |